In order to meet the growing needs of the new drugs and to become a leading healthcare provider,Swiss Garnier life Sciences,an innovative company manufacturing a wide range of pharmaceutical, neutraceutical and  FMCG products in the dosage form of tablets, capsules, dry powder, liquids and now into ointments, is setting up new facilities in Sikkim and Puducherry.

Plans are also afoot to set up USFDA level facility exclusively for exports and to market its own pharmaceutical products in India. It has initiated exporting its products to Nepal , Sri Lanka , Ghana, Malaysia, Tanzania, Cambodia and to Asian countries.

The company has developed expertise in sustained release and  extended release formulations with spectacular success. Swiss Garnier’s pioneering efforts to develop the Method of Analysis for dissolution of Voglibose and other leading molecules have gained plaudits from the industry.

The launch of Thiocolchicoside , Doxophylline with Montelukast, SAMe ( S-Adenosyl Methionine) are the company’s break through formulations in the market. Swiss Garnier has also introduced new products in the form of tablet in tablet, capsule in capsule, tablet in capsule etc. Around 32 DCGI approved combinations are  also in  its basket. The company’s current growth plan includes marketing in gynaecology & dermatology.

Swiss Garnier Life Sciences , which has gained a pre-eminent position in the Indian pharmaceutical manufacturing scene over the years , was established in the year 2006 at the foothills of Himalayas.

The Managing Director,M.S. Theivendran, a B. Tech graduate from Madras University, with significant experience from ONGC in R&D , product design and management ventured into the pharmaceutical manufacturing sector with a vision to cater the growing needs of the healthcare sector. This burning desire blossomed into Swiss Garnier and the company from day one is consistently growing in technology and other factors under his leadership.

As a proof to the saying “ There is a Women behind Every Man’s Success” – the Director    T. Rethinavalli, M.Sc. B. Ed is adding sheen to the business activities by heading the commercial team efficiently.

Swiss Garnier’s world class infrastructure has won ISO 9001: 2008 Certificate, WHO-GMP Certificate and also SME1 Certificate from CRISIL Ltd which indicates highest level of credit-worthiness. The company has well equipped R&D infrastructure manned by experienced scientists.

Driven with the state of the art technology , highly motivated people with good teamwork , the company has developed innovative products for many leading MNC’s. About 70 per cent of the products are outsourced by all the major pharma companies.  

Swiss Garnier Genexiaa Sciences : The facility in Sikkim is under construction with an area of 1.5 lakh square feet with the state of the art manufacturing facility complying with  US-FDA regulatory norms. Swiss Garnier focuses on niche product manufacturing platform combining cutting edge technology with well-equipped, modern, sophisticated and  latest machineries / equipment.  In Sikkim plant, in addition to solid dosage formulation, the company is  focussing on parenteral and dry injections.  Besides, it is also  concentrating on soft gel capsules and MDI.

Swiss Garnier Health Sciences : The facility equipped with modern equipment is located in Puducherry with an area of 50,000 sq. ft. complying with WHO GMP norms. Swiss Garnier Health Sciences concentrates more on the state of art research & development as well as  new molecule development.